ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome

dc.contributor.authorMartin Loeches, Ignacio
dc.contributor.authorGumucio Sanguino, Víctor D.
dc.contributor.authorTorres Martí, Antoni
dc.contributor.authoron behalf of CIBERESUCICOVID Project (COV20/00110 and ISCIII)
dc.date.accessioned2022-03-24T13:33:29Z
dc.date.available2022-03-24T13:33:29Z
dc.date.issued2021
dc.date.updated2022-03-24T13:33:29Z
dc.description.abstractBackground: Some patients previously presenting with COVID-19 have been reported to develop persistent COVID-19 symptoms. While this information has been adequately recognised and extensively published with respect to non-critically ill patients, less is known about the incidence and factors associated with the characteristics of persistent COVID-19. On the other hand, these patients very often have intensive care unit-acquired pneumonia (ICUAP). A second infectious hit after COVID increases the length of ICU stay and mechanical ventilation and could have an influence on poor health post-COVID 19 syndrome in ICU-discharged patients. Methods: This prospective, multicentre, and observational study was carrid out across 40 selected ICUs in Spain. Consecutive patients with COVID-19 requiring ICU admission were recruited and evaluated three months after hospital discharge. Results: A total of 1255 ICU patients were scheduled to be followed up at 3 months; however, the final cohort comprised 991 (78.9%) patients. A total of 315 patients developed ICUAP (97% of them had ventilated ICUAP). Patients requiring invasive mechanical ventilation had more persistent post-COVID-19 symptoms than those who did not require mechanical ventilation. Female sex, duration of ICU stay, development of ICUAP, and ARDS were independent factors for persistent poor health post-COVID-19. Conclusions: Persistent post-COVID-19 symptoms occurred in more than two-thirds of patients. Female sex, duration of ICU stay, development of ICUAP, and ARDS all comprised independent factors for persistent poor health post-COVID-19. Prevention of ICUAP could have beneficial effects in poor health post-COVID-19.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec721152
dc.identifier.idimarina9295867
dc.identifier.issn2077-0383
dc.identifier.pmid35011967
dc.identifier.urihttps://hdl.handle.net/2445/184387
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/jcm11010224
dc.relation.ispartofJournal of Clinical Medicine, 2021, vol. 11, num. 1, p. 224
dc.relation.urihttps://doi.org/10.3390/jcm11010224
dc.rightscc-by (c) Martin Loeches, Ignacio et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationPneumònia
dc.subject.classificationCOVID-19
dc.subject.classificationSARS-CoV-2
dc.subject.classificationPulmó
dc.subject.otherPneumonia
dc.subject.otherCOVID-19
dc.subject.otherSARS-CoV-2
dc.subject.otherLung
dc.titleICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
721152.pdf
Mida:
488.42 KB
Format:
Adobe Portable Document Format